
Allstate Elects Maria Morris to Board of Directors
The Allstate Corporation (ALL) announced that Maria Morris, 61, former Executive Vice President, Global Employee Benefits, MetLife (MET), has been elected to Allstate’s board of directors,...
The Allstate Corporation (ALL) announced that Maria Morris, 61, former Executive Vice President, Global Employee Benefits, MetLife (MET), has been elected to Allstate’s board of directors,...
Executives from PNC Financial (NYSE:PNC) Services and MetLife (NYSE:MET) are set to discuss their respective companies' strategies and performance at the upcoming Goldman Sachs (NYSE:GS)...
An analyst from Barclays initiated coverage of MetLife (NYSE: MET) at 'overweight' with a price target of $71.00. Prior to this rating, MetLife had 12 buy ratings, 5 hold ratings, and 0...
MetLife, Inc. (NYSE:MET) today announced it has completed its risk transfer transaction with Global Atlantic Financial Group, a retirement and life insurance company. The transaction...
An analyst from Wells Fargo maintained MetLife (NYSE: MET) at 'overweight' with a price target of $81.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
An analyst from Evercore ISI maintained MetLife (NYSE: MET) at 'outperform' with a price target of $86.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
MetLife Inc. (NYSE:MET) reported robust results for the third quarter of 2023, with a 35% year-over-year increase in adjusted earnings to $1.5 billion, or $1.97 per share. The company saw...
An analyst from BofA Securities maintained MetLife (NYSE: MET) at 'buy' with a price target of $82.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had 11...
An analyst from Morgan Stanley maintained MetLife (NYSE: MET) at 'overweight' with a price target of $80.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife...
Investing.com - MetLife (NYSE: MET) reported third quarter EPS of $1.97, $0.01 better than the analyst estimate of $1.96. Revenue for the quarter came in at $18.24B versus the consensus...
FOSTER CITY, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM), a late-stage clinical biopharmaceutical company developing multiple oncology drug candidates to...
FOSTER CITY, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Apollomics Inc. (NASDAQ:APLM) (the "Company"), today announced a report by the Veneto Institute of Oncology on the efficacy response...
An analyst from JPMorgan maintained MetLife (NYSE: MET) at 'overweight' with a price target of $82.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had 11...
MetLife (MET) declared a quarterly dividend of $0.52 per share, or $2.08 annualized.The dividend will be payable on December 14, 2023, to stockholders of record on November 9, 2023, with an...
An analyst from JPMorgan maintained MetLife (NYSE: MET) at 'overweight' with a price target of $82.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had 12...
An analyst from Deutsche Bank initiated coverage of MetLife (NYSE: MET) at 'hold' with a price target of $71.00. Prior to this rating, MetLife had 12 buy ratings, 4 hold ratings, and 0...
Investing.com -- U.S. futures traded higher Thursday, as investors digested the rise in headline consumer inflation ahead of more economic data to provide more clues of likely Federal...
An analyst from Jefferies upgraded MetLife (NYSE: MET) from 'hold' to 'buy' with a price target of $72.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
An analyst from Morgan Stanley maintained MetLife (NYSE: MET) at 'overweight' with a price target of $79.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife...
An analyst from Wells Fargo maintained MetLife (NYSE: MET) at 'overweight' with a price target of $83.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
An analyst from RBC Capital maintained MetLife (NYSE: MET) at 'outperform' with a price target of $74.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
An analyst from BofA Securities maintained MetLife (NYSE: MET) at 'buy' with a price target of $82.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had 11...
Investing.com - MetLife (NYSE: MET) reported second quarter EPS of $1.94, $0.01 better than the analyst estimate of $1.93. Revenue for the quarter came in at $16.62B versus the consensus...
MetLife (NYSE:MET) declared a quarterly dividend of $0.52 per share, or $2.08 annualized.The dividend will be payable on September 14, 2023, to stockholders of record on August 8, 2023, with...
An analyst from Jefferies maintained MetLife (NYSE: MET) at 'hold' with a price target of $58.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had 11 buy...
MetLife, Inc. (NYSE:MET) today announced that Steven J. Goulart, Chief Investment Officer and President of MetLife Investment Management, will retire on August 31, 2023, in line with the...
An analyst from Morgan Stanley maintained MetLife (NYSE: MET) at 'overweight' with a price target of $78.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife...
By Davit KirakosyanHere is your Pro Recap of the biggest fresh dividend hikes, suspensions, and stock buybacks you may have missed last week: dividend suspension at |Big Lots, hikes at...
An analyst from RBC Capital maintained MetLife (NYSE: MET) at 'outperform' with a price target of $65.00 from a prior price target of %currency%%price%. Prior to this rating, MetLife had...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.